1. Bundesweite und kleinräumige Kennzahlen zur Morbidität von Lyme–Borreliose in Deutschland anhand vertragsärztlicher Abrechnungsdaten, 2010 bis 2019;Akmatov,2021
2. Lower cardiorenal risk with sodium–glucose cotransporter–2 inhibitors versus dipeptidyl peptidase–4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: a large multinational observational study;Birkeland;Diabetes. Obes. Metab.,2021
3. Epidemiological surveillance of lyme borreliosis in Bavaria, Germany, 2013–2020;Bohmer;Microorganisms.,2021
4. Validation of claims–based algorithm for lyme disease, Massachusetts, USA;Cocoros;Emerg. Infect. Dis.,2023
5. Incidence of notified Lyme borreliosis in Germany, 2013–2017;Enkelmann;Sci. Rep.,2018